Table 3. Specificity and sensitivity of PCR on blood during post-treatment follow-up.
| Blood | ||||||
| Cured patients | Patients with treatment failure | |||||
| FU time point | Number of specimens | Number of positive PCRs | Specificity % (95% CI) | Number of specimens | Number of positive PCRs | Sensitivity % (95% CI) |
| Pre-treatment | 174 | 101 | 42.0 (34.6–49.3) | 134 | 109 | 81.3 (74.7–88.0) |
| 3 months | 169 | 33 | 80.5 (74.5–86.3) | 126 | 27 | 21.4 (14.2–28.7) |
| 6 months | 168 | 17 | 89.9 (85.3–94.5) | 80 | 10 | 12.5 (5.2–19.8) |
| 12 months | 157 | 12 | 92.4 (88.2–96.6) | 27 | 8 | 29.6 (12.0–47.3) |
| 18 months | 132 | 10 | 92.4 (87.9–97.0) | 10 | 2 | 20.0 (0–46.4) |
| 24 months | 160 | 30 | 81.2 (75.1–87.4) | 4 | 2 | 50 (0.0–1.0) |
Note. CI = confidence interval.